Intracoronary autologous CD34+ stem cell therapy for intractable angina
Background Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis.Persistent polymer, the drug, or a combination of both could be responsible.Methods We compared a combo stent (CS), a polymer-free sirolimus-eluting stent coated with anti-CD34 antibody,with a permanent-polymer sirolimus-eluing stent (SES), a polymer-free sirolimus-eluting stent (PFSES) and a bare-metal stent (BMS) at 14 days and 28 days in a porcine model with optical coherence tomography (OCT) and histological analysis.
ZHANG Tao CHEN Yun-dai TIAN Feng
Chinese PLA General Hospital,Beijing,China
国内会议
北京
英文
5-5
2013-03-20(万方平台首次上网日期,不代表论文的发表时间)